Position in ZLAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$827
+$810 QoQ
Shares Held
44
+4300.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Larson Financial Group LLC holds $4,056,513 across 195 Biotechnology names. ZLAB ranks #145 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,319 | $588,986 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
561 | $433,451 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
7,490 | $248,817 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
3,031 | $227,597 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,433 | $190,131 | |
| 6 | INCY |
Incyte Corp
|
1,602 | $150,780 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,806 | $119,033 | |
| 8 | MRNA |
Moderna, Inc.
|
2,166 | $110,032 |
All Filings in ZLAB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $827 | 44 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17 | 1 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $203 | 6 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||